Tumour-suppressor genes in prostatic oncogenesis: A positional approach

British Journal of Urology

Volumn 79, Issue SUPPL. 1, 1997, Pages 28-36

  Bookstein, R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 16Q; CHROMOSOME 18Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME ARM; COLON CANCER; CONFERENCE PAPER; GENE DELETION; GENE LOCUS; GENE MAPPING; GENE MUTATION; HUMAN; MALE; METHYLATION; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BLOTTING, SOUTHERN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; MALE; METHYLATION; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENES; PROSTATIC NEOPLASMS;

EID: 0031397328     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410x.1997.tb00798.x     Document Type: Article

References (73)

1. Huang H-JS, Yee J-K, Shew J-Y et al. Suppression of the neoplastic phenotype by replacement of the retinoblastoma gene product in human cancer cells. Science 1988; 242: 1563-6
2. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990; 247: 712-15
3. Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science 1990; 250: 1576-80
4. Takahashi R, Hashimoto T, Xu H-J et al. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sei USA 1991; 88: 5257-61
5. Banerjee A, Xu H-J, Hu S-X et al. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13. Cancer Res 1992; 52: 6297-304
6. Zhou Y, Li J, Xu K, Hu S-X, Benedict WF, Xu H-H. Further characterisation of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sei USA 1994; 91: 4165-9
7. Goyette MC, Cho K, Fasching CL et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Moi Cell Biol 1992; 12: 1387-95
8. Groden J, Joslyn G, Samowitz W et al. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 1995; 55: 1531-9
9. Holt JT, Thompson ME, Szabo C et al. Growth retardation and tumour inhibition by BRCA1. Nature Genet 1996; 12: 298-302
10. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC. p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 1993; 53: 3369-73
11. Navone NM, Troncoso P, Pisters LL et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993; 85: 1657-69
12. Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, CordonCardo C. Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol 1994; 151: 1276-80
13. Bookstein R, Rio P, Madreperla S et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci; USA 1990; 87: 7762-6
14. Kubota Y, Fujlnami K, Uemura H et al Retinoblastoma gene mutations in primary human prostate cancer. Prostate 1995: 27: 314-20
15. Phillips SMA, Barton CM, Lee SJ et al Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 1994; 70: 1252-7
16. Bookstein R. Tumor suppressor genes in prostatic oncogenesis. J Cell Biochem 1994; S19: 217-23
17. Herman JG, Merlo A, Mao L et al. Inactivation of the CDKN2/pl6/MTSl gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-30
18. Cairns P, Polascik TJ, Eby Y et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet 1995; 11: 210-12
19. Taplin ME, Bubley GJ, Shuster TD et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. NEnglJMed 1995; 332: 1393-8
20. Visakorpi T, Hyytinen E, Koivisto P et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 1995: 9: 401-6
21. McDonnell TJ, Troncoso P, Brisbay SM et al. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52: 6940-4
22. Carter BS, Ewing CM, Ward WS et al. Allelic loss of chromosomes 16q and lOq in human prostate cancer. Proc Natl Acad Sei VSA 1990; 87: 8751-5
23. Kunimi K, Bergerheim USR, Larsson I-L, Ekman P, Collins VP. Allelotyping of human prostatic adenocarcinoma. Genomics 1991; 11: 530-6
24. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 1994; 54: 6370-3
25. Visakorpi T, Kallioniemi AH, Syvanen A-C et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridisation. Cancer Res 1995; 55: 342-7
26. Bergerheim USR, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes, 8,10, and 16 in human prostate carcinoma. Genes Chromosom Cancer 1991; 3: 215-20
27. Kerangueven F, Essioux L, Dib A et al. Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 1995; 10: 1023-6
28. Vogelstein B, Fearon ER, Kern SE et al. Allelotype of colorectal carcinomas. Science 1989; 244: 207-11
29. Knowles MA, Shaw ME, Proctor AJ. Deletion mapping of chromosome in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 1993; 8: 1357-64
30. Cher ML, Bova GS, Moore DH et al. Genetic alterations in untreated prostate cancer metastases and androgen independent prostate cancer detected by comparative genomic hybridisation and allelotyping. Cancer Res 1996; 56: 3091-102
31. Emmert-Buck MR, Vocke CD, Pozzatti RO et al. Allelic loss on chromosome 8pl2-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995; 55: 2959-62
32. MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosom Cancer 1994; 10: 151-9
33. Fujiwara Y, Emi M, Ohata H et al. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 1993; 53: 1172-4
34. Emi M, Fujiwara Y, Nakajima T et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992: 52: 5368-72
35. Ohata O, Emi M, Fujiwara Y et al. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosom Cancer 1993; 7: 85-8
36. Bova GS, Carter BS, Bussemakers MJG et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993; 53: 3869-73
37. Emi M, Fujiwara Y, Ohata H et al. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosom Cancer 1993: 7: 152-7
38. Fujiwara Y, Ohata H, Emi M et al. A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosom Cancer 1994; 10: 7-14
39. Suzuki H, Emi M, Komiya A et al. Localisation of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3. Genes Chromosom Cancer 1995: 13: 168-74
40. Trapman J, Sleddens HFBM, Weiden MM et al. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 1994; 54: 6061-4
41. Macoska JA, Trybus TM, Benson PD et al. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995; 55: 5390-5
42. Schutte M, Costa LT, Hahn SA et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sei USA 1995; 92: 5950-4
43. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92
44. Bookstein R, Levy A. MacGrogan D et al. Yeast artificial chromosome and radiation hybrid map of loci in chromosome band 8p22, a common region of allelic loss in multiple human cancers. Genomics 1994; 24: 317-23
45. Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 1996; 35: 46-54
46. Fujiwara Y, Ohata H, Kuroki T et al. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene 1995; 10: 891-5
47. MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 1996; 35: 55-65
48. Karaoglu D, Kelleher DJ, Gilmore R. Functional characterisation of Ost3p. Loss of the 34-kD subunit of the Saccharomyces cerevisiae oligosaccharyltransferase results in biased underglycosylation of acceptor substrates. J Cell Biol 1995; 130: 567-77
49. Das RC, Heath EC. Dolichyldiphosphoryloligosaccharide -protein oligosaccharyltransferase; solubilisation, purification, and properties. Proc Natl Acad Sci USA 1980; 77: 3811-15
50. Kelleher DJ, Gilmore R. The Saccharomyces cerevisiae oligosaccharyltransferase is a protein complex composed of Wbplp, Swplp, and four additional polypeptides. J Biol Chem 1994; 269: 12908-17
51. Silberstein S, Kelleher DJ, Gilmore R. The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1. J Biol Chem 1992; 267: 23658-63
52. Silberstein S, Collins PG, Kelleher DJ, Rapiejko PJ, Gilmore R. The α subunit of the Saccharomyces cerevisiae oligosaccaryltransferase complex is essential for vegetative growth of yeast and is homologous to mammalian ribophorin I. J Cell Biol 1995; 128: 525-36
53. Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet 1994; 3: 1487-95
54. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991; 48: 880-8
55. Herman JG, Latif F, Weng Y et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sei USA 1994; 91: 9700-4
56. Bird A. The essentials of DNA methylation. Cell 1992; 70: 5-8
57. Wales MM, Biel MA, Deiry WE et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17pl3.3. Nature Med 1995; 1: 570-7
58. Bustros Ad, Nelkin BD, Silverman A, Erblich G, Poiesz B, Baylin SB. The short arm of chromosome 11 is a 'hot spot' for hypermethylation in human neoplasia. Proc Natl Acad Sei USA 1988; 85: 5693-7
59. Ichikawa T, Nihei N, Suzuki H et al. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res 1994; 54: 2299-302
60. Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Oshimura M, Miyaki M. Suppression of tumorigenicity and invasiveness of colon carcinoma cells by introduction of normal chromosome 8pl2-pter. Oncogene 1996; 12: 405-10
61. Sanchez Y, Lovell M, Marin MC et al. Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-qll. Proc Natl Acad Sei USA 1996; 93: 2551-6
62. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nature Genet 1995; 9: 249-55
63. Ichikawa T, Ichikawa Y, Dong J et cd. Localisation of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 1992; 52: 3486-90
64. Rinker-Schaeffer CW, Hawkins AL, Ru N et al. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994; 54: 6249-56
65. Murakami YS, Brothman AR, Leach RJ, White RL. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 1995; 55: 3389-94
66. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate carcinoma cancer cells containing mutant p53 alleles. Cancer Res 1991; 51: 4716-20
67. Yang C, Cirielli C, Capogrossi MC, Passaniti A. Adenovirusmediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res 1995; 55: 4210-13
68. Dong JT, Lamb PW, Rinker-Schaeffer CW et al. KAI l, a metastasis suppressor gene for prostate cancer on human chromosome llpll.2. Science 1995; 268: 884-6
69. Adachi M, Taki T, leki Y, Huang C-L, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996; 56: 1751-5
70. Umbas R, Schalken JA, Aalders TW et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-9
71. Umbas R, Isaacs WB, Bringuier PP et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54: 3929-33
72. Ewing CM, Ru N, Morton RA et ai. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 1995; 55: 4813-17
73. Lee W-H, Morton RA, Epstein JI et al. Cytidine methylation of regulatory sequences near the p-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sei USA 1994; 91: 11733-7